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The frequency of severe systemic fungal diseases has increased in the last few decades. The 
clinical use of antibacterial drugs, immunosuppressive agents after organ transplantation, cancer 
chemotherapy, and advances in surgery are associated with increasing risk of fungal infections. 
Opportunistic pathogens from the genera Candida and Aspergillus as well as pathogenic fungi 
from the genus Cryptococcus can invade human organism and may lead to mucosal and skin in-
fections or to deep-seated mycoses of almost all inner organs, especially in immunocompromised 
patients. Nowadays, there are some effective antifungal agents, but, unfortunately, some of the 
pathogenic species show increasing resistance. The identification of fungal virulence factors and 
recognition of mechanisms of pathogenesis may lead to development of new efficient antifungal 
therapies. This review is focused on major virulence factors of the most common fungal patho-
gens of humans: Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. The ad-
herence to host cells and tissues, secretion of hydrolytic enzymes, phenotypic switching and mor-
phological dimorphism contribute to C. albicans virulence. The ability to grow at 37°C, capsule 
synthesis and melanin formation are important virulence factors of C. neoformans. The putative 
virulence factors of A. fumigatus include production of pigments, adhesion molecules present on 
the cell surface and secretion of hydrolytic enzymes and toxins. 
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InTrOduCTIOn
In the last decades the problem of severe 
nosocomial fungal diseases has become more seri-
ous, especially in patients with severe immunologi-
cal impairment. The development of medicine, sur-
gery and transplantology in the last thirty years has 
caused a dramatic increase in the number of immu-
nocompromised individuals who are more suscepti-
ble to fungal infections. Patients with immunological 
impairment, HIV infection, leukopenia (haematologi-
cal malignancy patients), after surgery, organ trans-
plantation or cancer therapy are at risk of develop-
ing mycoses. Widespread use of broad-spectrum 
antimicrobial agents, immunosuppressive agents 
and corticosteroid therapy are also risk factors. The 
prophylactic use of antifungal therapies is one of the 
reasons of frequent resistance to antifungal drugs 
(Perfect & Casadevall, 2006; d’Enfert & Hube, 2007). 
Among all the fungi only few species are pathogenic 
to humans. The most frequently diagnosed fungal 
infections are caused by pathogens from the gen-
era Candida, Cryptococcus and Aspergillus (Richard-
son, 2005). These fungi are ubiquitous and can be 
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acquired from host surroundings (Cryptococcus neo-
formans, Aspergillus fumigatus) or are components of 
normal endogenous flora (Candida albicans) (Perfect 
& Casadevall, 2006). The mortality among infected 
patients is high, even after intensive antifungal treat-
ment, because of patient’s immunodeficiency, late 
diagnosis or fungal drug resistance. Fungi are able 
to cause a disease and to overwhelm the host de-
fense systems because of possessing several genes 
and proteins associated with their pathogenicity, 
called virulence factors (Tomee & Kauffman, 2000). 
Many of the putative fungal virulence factors have 
developed naturally during organism evolution and 
originally acted as a defense against unfavorable en-
vironmental conditions, and then, in this way, many 
of them became important as virulence factors facili-
tating infection.
CAndidA AlbiCAns
Currently more than two hundred ascomyc-
etous yeasts are included into the genus Candida, 
but only a few species are opportunistic pathogens 
of humans. Nowadays, Candida albicans is thought 
to be the major fungal pathogen of humans. Severe 
Candida infections are a serious problem, especially 
in individuals whose immune defense mechanisms 
have been weakened (Odds et al., 2006). C. albicans 
can colonize skin and mucosal surfaces of healthy 
people and thus occurs commensally in the gastroin-
testinal tract, oral cavity and vagina, often causing 
superficial infections (Mavor et al., 2005). Moreover, 
C. albicans can enter the bloodstream by direct pen-
etration from the epithelium after tissue damage, or 
by dissemination from biofilms formed on medical 
devices introduced into the patient’s organism, e.g. 
catheters, dental implants, endoprostheses, artificial 
joints or central nervous system shunts (Chandra et 
al., 2001; Mavor et al., 2005). Then yeast cells dissem-
inate with the blood flow and infect almost all inner 
organs, including lungs, kidney, heart, liver, spleen 
and brain, causing fungaemia and life-threatening 
septicaemia. Candidiasis may occur as a result of 
disturbed balance between host immunity and this 
opportunistic pathogen. This disorder is not only 
due to the immunological dysfunction of the host, 
but also to the fungal ability to adapt to new niches, 
dependent on the expression of infection-associated 
genes (Brown et al., 2007a). These genes and their 
products contribute to fungal pathogenicity and are 
described as virulence factors. C. albicans virulence 
factors include, among others, production of differ-
ent hydrolytic enzymes and adhesins (Chaffin et al., 
1998). There are also other characteristic properties 
that influence fungal virulence, for example, the abil-
ity to form biofilms on various surfaces, to change 
morphological form and to switch between various 
phenotypes (Chaffin et al., 1998).
Phenotypic switching
Phenotypic switching is a very important part 
of fungal adaptability to the changing of environ-
ment during invasion of the human organism. The 
ability to infect many tissues is crucial to a success-
ful attack and dissemination within the host. Occa-
sionally some subpopulations of C. albicans cells can 
change their morphology, cell surface properties, 
colony appearance, biochemical properties and me-
tabolism to become more virulent and more effective 
during infection (Odds et al., 2006). Colonies change 
their appearance and assume different shapes, in-
cluding smooth, rough, fuzzy, wrinkled, fringed or 
stippled phenotype with a high frequency, approxi-
mately one changed colony per 10–104 colonies (Slut-
sky et al., 1985). The molecular basis of this process 
is still unclear. Probably chromosomal rearrange-
ments and a SIR2-like regulation take part in this 
process (Calderone & Fonzi, 2001). The most popu-
lar and well-known example of switched colonies is 
the white — opaque switching, when a white, oval 
and smooth colony changes into a grey, rough col-
ony (Slutsky et al., 1987). The opaque cells produce 
aspartyl proteinases 1 and 3 and are less virulent, 
whereas white cells secrete aspartyl proteinase 2 and 
are more virulent during systemic infection (Yang, 
2003). Phenotypic switching is most likely a signal 
of large-scale processes involving changes of many 
molecular and biochemical properties of the patho-
gen, which are helpful for fungi to survive within 
the host organism.
Morphological dimorphism
The ability to switch between unicellular 
yeast cells and filamentous forms called hyphae 
and pseudohyphae is known as morphological di-
morphism. The transition between these different 
morphological forms in response to diverse stimuli 
seems to be very important for fungal pathogenicity 
(Lo et al., 1997; Chaffin et al., 1998). The morphology 
can change under a variety of environmental condi-
tions, including response to physiological tempera-
ture of 37°C, pH equal to or higher than 7.0, CO2 
concentration of 5.5% or the presence of serum or 
carbon sources which stimulate hyphal growth (Eck-
ert et al., 2007). The production of unicellular forms 
is stimulated by lower temperatures and more acidic 
pH, absence of serum and high concentrations of 
glucose (Whiteway & Bachewich, 2006). Yeast cells 
are thought to be responsible for dissemination in 
the environment and finding new hosts, while hy-
phae are required for tissue damage and invasion. 
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Both forms are present in biofilms formed on artifi-
cial substrates (Chandra et al., 2001). Yeast cells have 
different properties than the mycelial forms: the ul-
trastructure, biological attributes and composition of 
the cell wall differ between these forms. Probably 
both forms, yeast cells and hyphae, are necessary 
for full virulence, because mutants lacking genes 
responsible for the production of one or the other 
are less virulent (Yang, 2003). Despite the fact that 
the production of filamentous form is well known 
among the pathogenic fungi, the molecular basis of 
C. albicans morphological dimorphism is still poorly 
understood. Many genes associated with the forma-
tion of different cell shape code for transcription fac-
tors and may be also responsible for expression of 
unknown genes, encoding other virulence factors. 
Recent studies show that the transcription factor 
Cph1p, whose phosphorylation is regulated through 
a mitogen-activated protein (MAP) kinase pathway 
involving products of genes CST20, HST7 and CEK1, 
and the basic helix-loop-helix transcription factor 
Efg1p are required to form hyphae during infection 
(Lo et al., 1997). In the Efg1p pathway, the follow-
ing proteins are involved: homologs of Ras, adenyl 
cyclase and protein kinase A (TPK2) (Brown & Gow, 
1999; Lengeler et al., 2000). Other transcription fac-
tors, Tup1p and Rbp1p, are negative regulators of 
filamentation, because mutants lacking these genes 
exhibit constitutive filamentation (Calderone & Fon-
zi, 2001; Yang, 2003). Other putative factors may 
contribute to morphogenesis, but their role and exact 
function are so far unknown. It is only obvious that 
co-operation of all the signaling pathways involved 
in the morphological transition is very important for 
fungi to infect and survive in the human host.
Adhesion and adhesion molecules
The adherence to the host cells and tissues, as 
well as the binding of a set of diverse host proteins 
is essential for C. albicans to begin the invasion, fol-
lowed by dissemination within the human organ-
ism. This step is crucial for fungal survival. On the 
cell wall surface C. albicans presents receptors which 
are responsible for adhesion to epithelial and en-
dothelial cells, serum proteins and extracellular ma-
trix proteins (Chaffin et al., 1998). Adhesion to dif-
ferent artificial substrates and formation of biofilm 
on medical devices is currently a serious problem in 
medicine, because of the frequent resistance to an-
tifungal agents and increased pathogenicity among 
the subpopulation of cells forming the biofilm. It has 
been estimated that in the last few decades microbial 
infections of humans are strictly correlated with bio-
film formation in 65% of cases (Ramage et al., 2006). 
C. albicans cells originally present either on the skin, 
mucosal surfaces or in blood can colonize the sur-
face of medical devices. All known morphological 
forms, yeast cells, pseudohyphae and hyphae, form 
a biofilm and they have different properties than 
those of planktonic or suspended cells (Al-Fattani & 
Douglas, 2006). The secretion of aspartyl proteinases 
(SAPs) is higher during biofilm formation (Mendes 
et al., 2007). C. albicans cells forming a biofilm are al-
ways associated with a matrix composed of polysac-
charides containing mannose and glucose residues 
(Chandra et al., 2001). The biofilm matrix produc-
tion plays a very important role in drug resistance 
of C. albicans biofilms, but development of resistance 
is rather multifactorial (Al-Fattani & Douglas, 2006). 
During biofilm formation, C. albicans cells express 
several genes that influence pathogenicity. Products 
of these genes take part in adhesion (e.g. family of 
Als proteins), in carbohydrate synthesis, drug re-
sistance (e.g. efflux pumps) and in quorum sensing 
(Chandra et al., 2001).
The ability of Candida to invade different en-
vironments in the host organism is a result of great 
flexibility and adaptability of fungi. This phenome-
non is in part due to the presence of different adhes-
ins connected with cell surface, which facilitate the 
first stage of infection. These adhesins include Als 
proteins family, Hwp1p, Eap1p, Csh1p, and other 
less known cell surface receptors. The C. albicans cell 
wall is constructed from β-glucans (branched poly-
mers of glucose residues containing β-1,3 and β-1,6 
linkages), chitin (unbranched polymers of N-acetyl-
d-glucosamine (GlcNAc) containing β-1,4 bonds), 
mannoproteins, small amounts of other proteins and 
lipids (Chaffin et al., 1998). All known receptors are 
tightly connected with the fungal cell wall. The fam-
ily of Als proteins (“agglutinin-like sequence”) is 
one of the well-known examples of Candida adhes-
ins. This family includes at least eight ALS genes 
that encode proteins with similar structure, which 
are connected to the cell surface (Fig. 1). Despite 
the fact that members of this family have different 
functions and different sizes, their structures exhibit 
some common properties. In 2004, Sheppard and 
coworkers described the structure of the N-terminal 
fragment of Als proteins. This part contains multi-
ple antiparallel β-sheet domains containing minor α-
helical and β-turn components, which indicates that 
products of ALS genes are members of immunoglob-
ulin family (Sheppard et al., 2004). Als1p, Als3p and 
Als5p are believed to be responsible for adherence 
to collagen, fibronectin, laminin, endothelial and 
epithelial cells, Als6p binds to collagen and Als9p 
to laminin. Als4p probably mediates adherence to 
endothelium, and Als5p is additionally responsi-
ble for cell-to-cell aggregation. The role of Als7p is 
still unknown (Filler et al., 2006). A receptor with a 
molecular mass of approx. 34 kDa, which is present 
only on the surface of hyphal cells, is called Hwp1p 
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(Chaffin et al., 1998). The structure of Hwp1p is 
similar to that characteristic for Als proteins, but un-
like those, Hwp1p possess in its N-terminal part a 
sequence similar to those of small proline-rich pro-
teins of human cells which are substrates for trans-
glutaminases present on the surface of epithelial 
cells. Therefore, Hwp1p facilitates adhesion to epi-
thelium (Staab et al., 1999). Another receptor, Eap1p 
(“enhanced adhesion to polystyrene 1”), shows ho-
mology and structural similarity to Hwp1p, but 
the host ligands for this protein are still unknown 
(Filler et al., 2006). There are also other receptors of 
different structure, for example Int1p containing an 
integrin-like domain and an RGD-binding domain, 
which bind to different extracellular matrix proteins 
including fibronectin, entactin, vitronectin, laminin 
and collagen, and take part in adhesion to platelets 
and endothelial cells (Chaffin et al., 1998; Calderone 
& Fonzi, 2001; Ruiz-Herrera et al., 2006). Although 
the role of alcohol dehydrogenase, Adh1p, in bind-
ing of C. albicans cells to fibronectin is still unclear 
this protein is also thought to have adhesive proper-
ties (Filler et al., 2006). Host serum proteins, includ-
ing fibrinogen (Casanova et al., 1992), plasminogen 
(Crowe et al., 2003), kininogen (Rapala-Kozik et al., 
2008) and others can also be bound by C. albicans 
cells through different receptors, from which some 
are known and partially characterized. A tighter ad-
herence to epithelial and endothelial cells, as well as 
to extracellular matrix proteins is achieved thanks 
to increased cell surface hydrophobicity. Singleton 
et al. (2001) have described a novel 38-kDa receptor, 
Csh1p, which enhances hydrophobicity of C. albicans 
cells, also facilitating specific receptor-ligand interac-
tions. Adhesion to host cells is also dependent on 
interactions between mannoproteins with lectin-like 
properties and fucosyl or glucosaminyl glycosides 
on epithelial cells’ surface (Ruiz-Herrera et al., 2006). 
Although many fungal adhesins have been iden-
tified, so far little is known about the host recep-
tors involved in adhesion. At present it is obvious 
that Toll-like receptors 2 and 4 and other receptors 
present on the surface of human immune cells, such 
as monocytes, macrophages and dendritic cells, are 
involved in these interactions. Probably some pro-
teins present on the surface of epithelial or endothe-
lial cells, for example N-cadherin, are important for 
binding of different morphological forms of C. albi-
cans cells, followed by their endocytosis (Phan et al., 
2005; Filler, 2006). Due to the ability to bind and in-
vade human endothelial cells C. albicans can traverse 
the human blood-brain barrier and cause life-threat-
ening meningitis (Jong et al., 2001).
Secreted hydrolytic enzymes
Production and secretion of hydrolytic en-
zymes, such as proteases, lipases and phospholi-
pases are very important virulence factors. These 
enzymes play a role in nutrition but also in tissue 
damage, dissemination within the human organism, 
iron acquisition and overcoming the host immune 
system, and strongly contribute to fungal patho-
genicity. Many types of secreted hydrolytic enzymes 
are currently known for C. albicans. The activity of 
phospholipases is very high during tissue invasion, 
because these enzymes are responsible for hydroly-
sis of one or more ester linkages of glycerophos-
pholipids, of which the cell membrane is built. C. al-
bicans cells isolated from blood produce higher ex-
tracellular phospholipase activities than commensal 
strains (Ibrahim et al., 1995). There are four types of 
secreted phospholipases: A, B, C and D (Calderone 
& Fonzi, 2001; Yang, 2003), specific towards indi-
vidual ester bonds in glycerophospholipids (Ghan-
noum, 2000). Very important for fungal virulence 
is the activity of phospholipase B (PLB), which has 
both hydrolase and lysophospholipase-transacylase 
activities (Ghannoum, 2000; Yang, 2003). Thus, PLB 
can release fatty acids from a phospholipid and the 
Figure 1. Scheme of Als adhesin structure. 
The N-terminal fragment contains a putative signal pep-
tide and a ligand-binding domain, central region is rich in 
tandem repeats with many serine and threonine residues, 
as well as consensus sites for glycosylation. The C-termi-
nal part contains a glycosylphosphatidylinositol (GPI) an-
chorage site. After Filler et al. (2006), modified.
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remaining fatty acid from a lysophospholipid, and 
then transfer a free fatty acid to a lysophospholi-
pid and produce phospholipids (Theiss et al., 2006). 
Apart from phospholipases, C. albicans can produce at 
least nine lipases which can hydrolyze ester bonds of 
mono-, di-, and triacylglycerols (Schaller et al., 2005). 
A well-known group of C. albicans secreted hydro-
lytic enzymes are SAPs (secreted aspartyl protein-
ases). The family of SAP genes includes at least ten 
different genes SAP1–SAP10 which encode enzymes 
with similar functions and character, but different 
molecular properties, such as molecular mass, iso-
electric point and pH for optimal activity (Naglik et 
al., 2003). The expression of the SAP genes is regu-
lated at the transcriptional level, and the nascent 
preproprotein is processed by a signal peptidase in 
the endoplasmatic reticulum and by a Kex2-like pro-
teinase at the carboxyl-terminal side in the Golgi ap-
paratus (Newport & Agabian, 1997; Yang, 2003). The 
mature enzymes have molecular masses in the range 
of 35–48 kDa and two highly conserved regions 
with reactive aspartic residues, just as other pepsine-
like proteinases (Schaller et al., 2005). Probably SAPs 
1–3 are secreted only by yeast cells and SAPs 4–6 by 
hyphal forms (Naglik et al., 2004; White & Agabian, 
1995), whereas both forms produce SAPs 9 and 10, 
which are connected with fungal cell walls because 
of possessing a GPI anchorage site (Hube & Naglik, 
2001; Albrecht et al., 2006). The synthesis and func-
tion of SAPs 7 and 8 are still under investigation 
(Yang, 2003). Many host proteins are hydrolyzed 
by secreted aspartyl proteinases, including colla-
gen, laminin, fibronectin, mucin, salivary lactofer-
rin, α2-macroglobulin, almost all immunoglobulins, 
the proinflammatory cytokine interleukin-1β, lac-
toperoxidase, cathepsin D, complement, cystatine A, 
and precursors of several blood coagulation factors 
(Fig. 2) (Naglik et al., 2004; Schaller et al., 2005). The 
spectrum of optimal pH for SAPs activity is from 
2.0 to 7.0, therefore these enzymes may contribute 
to fungal pathogenesis and developing infections in 
different sites in the human organism (Naglik et al., 
2004). Except aspartyl proteinases, C. albicans also 
secrets other proteases: a 60-kDa metallopeptidase 
and a 50-kDa serine peptidase. The serine peptidase 
is active in a broad range of pH (5.0–7.2) and hy-
drolyzes many host substrates including extracellu-
lar matrix proteins and serum proteins (dos Santos 
et al., 2006).
Other virulence factors
The ability of pathogenic microorganisms to 
acquire iron from the environment during infection 
is another very important virulence factor. The abil-
ity to overcome host systems connected with iron 
transport and accumulation is crucial for the patho-
gen to survive during invasion of the bloodstream. 
In C. albicans members of Rbt5 family are needed for 
utilization of hemoglobin and hemin for iron acquisi-
tion by the pathogen. Without these proteins the C. 
albicans iron metabolism is severely impaired (Weiss-
men & Kornitzer, 2004). During infection Candida 
cells are exposed to reactive oxygen species produced 
by immune cells, hence the organism expresses sev-
eral virulence factors which help to overcome this 
host defense mechanism, including catalase, super-
oxide dismutase and heat shock proteins (Brown et 
al., 2007a). Expression of many virulence factors often 
depends on environmental conditions, therefore fun-
gi must possess a sensor for environmental changes. 
Probably calcineurin plays the role of such a sensor. 
Calcineurin is a highly conserved protein involved in 
fungal stress responses, composed of two subunits, 
the A subunit with catalytic activity and the B subunit 
with a regulatory function (Blankenship et al., 2003). 
The catalytic subunit is encoded by the CMP1 gene 
(Bader et al., 2003). As a result of calcium influx cal-
modulin binds to calcineurin A subunit, inhibits the 
action of the autoinhibitory C-terminal domain of the 
A subunit, and leads to the formation of the active 
calcineurin complex, which has a protein phosphatase 
activity. Afterwards calcineurin may influence the ex-
pression of several virulence factors of C. albicans. In 
the case of C. albicans it was shown by Blankenship 
et al. (2003) that calcineurin is dispensable for growth 
at 37°C, germ tube formation, and adherence to the 
host cells, but is essential for survival in the human 
serum, so fungal pathogenicity strongly correlates 
with its activity.
Figure 2. Substrates hydrolyzed by secreted aspartyl pro-
teinases (SAPs) during infection.
Based on data of Naglik et al. (2003) and Schaller et al. 
(2005).
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CryptoCoCCus neoformAns
Cryptococcus neoformans is a saprophytic, basid-
iomycetous, dimorphic organism found worldwide, 
because its natural habitats are pigeon droppings 
and contaminated soil. Small-sized basidiospores (1.8 
to 3.0 μm) (Buchanan & Murphy, 1998; Lin & Heit-
man, 2005) can turn into yeast cells, the form pre-
ferred at 37°C, or can form dikaryotic hyphae which 
are favored at 24°C (Whiteway & Bachewich, 2006). 
The haploid yeast cells are the asexual form of C. 
neoformans found in tissues during fungal infection 
as well as in standard laboratory media. In contrast, 
the diploid sexual form, hyphae, which is unstable 
and transient,  is found during culture of MATα and 
MATa strains on minimally nutritious media such as 
V-8 juice agar (Sia et al., 2000; Perfect, 2006).  The α 
strains, which are thought to be more virulent than 
a strains, can undergo a true dimorphic transition 
from haploid yeast cells to haploid hyphal cells pro-
ducing viable basidiospores (Wickes et al., 1996). Ba-
sidiospores or yeast cells may be inhaled by humans, 
then through the respiratory tract the pathogen can 
disseminate within the organism causing pulmonary 
infections, and subsequently, due to the C. neoformans 
predilection for the central nervous system, the life-
threatening meningoencephalitis both in immuno-
compromised and immunocompetent patients. If the 
infection of the central nervous system is not cured, it 
is fatal in 100% of cases (Buchanan & Murphy, 1998), 
and even after treatment the mortality rate is between 
10% and 25% (Perfect & Casadevall, 2002). Since the 
human immune system is in almost all cases able to 
overcome the intruder, infections can often pass with-
out symptoms, but sometimes even immunocompe-
tent patients can contract a severe disease. In patients 
after surgery, organ transplantation, with HIV infec-
tion or other malignancies, infections are more serious 
and lead to high mortality (Mitchell & Perfect, 1995; 
Perfect & Casadevall, 2002). This fungal pathogen is 
less known than Candida species, but nowadays the 
morbidity and mortality caused by cryptococcosis is a 
significant problem. In medically advanced countries 
about 5–10% of patients with AIDS develope crypto-
coccosis (Subramanian & Mathai, 2005); this infection 
rate is higher in developing countries and reaches 
13–45% (Hakim et al., 2000). Cryptococcocal infec-
tion was also documented in 2.8% of solid transplant 
recipients with a mortality rate near 42% (Husain et 
al., 2001).  The most important virulence factors of C. 
neoformans are: capsule production, melanin synthesis 
and the ability to grow at 37°C (Perfect, 2006).
Capsule formation
A thick polysaccharide capsule can be ob-
tained by C. neoformans during lung infection, in 
contrast to the natural environment where it is 
weakly encapsulated. After the invasion, C. neoform-
ans can be rehydrated and acquires the capsule com-
posed of glucuronoxylomannan (GXM) (Buchanan 
& Murphy, 1998) made of unbranched chains of α-
1,3-linked mannose units substituted with β-1,2- and 
β-1,4-xylose and β-1,2-glucuronic acid residues and 
connected with the fungal cell wall through glucan 
bridges (Bhattacharjee et al., 1984; Todaro-Luck et al., 
1989). α-1,3-Glucan found in the cryptococcal cell 
wall is very important for these interactions (Reese 
& Doering, 2003). This structure is similar in com-
position among different serotypes of C. neoformans 
but differs in antigenicity (McFadden et al., 2007). At 
least two genes, CAP59 and CAP64, are necessary 
for capsule formation (Chang & Kwon-Chung, 1994; 
Chang et al., 1996). The capsule has many important 
properties and functions; due to its negative charge 
it shields the pathogen from phagocytosis and killing 
by neutrophils, monocytes and macrophages. It is 
also responsible for complement depletion, antibody 
unresponsiveness and dysregulation of cytokine se-
cretion by monocytes and macrophages, including 
TNFα, IL-1β and IL-6. The capsule can inhibit the 
migration of leukocytes from the bloodstream to the 
inflammation sites (Buchanan & Murphy, 1998; Per-
fect, 2006). Though the capsule has evolved as a C. 
neoformans defense against adverse environmental 
conditions such as amoeba attack, it is also useful 
for invasion of the human organism, facilitating de-
velopment of infection.
Melanogenesis
The presence of melanin, a grayish, brown 
or black pigment, in the C. neoformans cell wall 
may be a result of fungal adaptation to environ-
mental changes (Plonka & Grabacka, 2006). It 
provides protection against ultraviolet radiation, 
extreme temperatures and other adverse environ-
mental conditions. However, the ability to produce 
melanin is also one of the important cryptococcal 
virulence factors, which facilitates fungal escape 
from lungs and infection of the central nervous 
system (Perfect, 2006). C. neoformans has a simple 
pathway for melanogenesis, but it must be able to 
acquire substrates, diphenolic compounds, from 
the surroundings because it lacks the tyrosinase 
enzyme (Fig. 3) (Polacheck & Kwon-Chung, 1988; 
Torres-Guererro & Edman, 1994). The construction 
and character of the produced pigment depends 
on the chemical structure of substrates, thus mela-
nins synthesized from o-diphenols with hydroxyl 
groups in the 2,3- or 3,4-positions are usually dark 
and connected with the cell wall while melanins 
produced from p-diphenols with hydroxyl groups 
in the 1,4- or 2,5-positions are soluble (Chaskes & 
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Tyndall, 1975). A phenoloxidase called laccase is 
the crucial cooper-containing enzyme responsible 
for the conversion of diphenolic compounds to 
dopaquinone, followed by their polymerization to 
melanin (Williamson, 1994). Laccase is anchored in 
the fungal cell wall (Polacheck et al., 1982). There 
are two paralog genes, CNLAC1 and CNLAC2, en-
coding laccase (Zhu & Williamson, 2004). During 
central nervous system infection, C. neoformans may 
use neurotransmitters such as dopamine, norepine-
phrine and epinephrine as substrates for melanin 
production (Casadevall et al., 2000). Some proper-
ties of melanin facilitate fungal survival during in-
fection. It protects fungi from reactive oxygen spe-
cies and plays a role as an antioxidant. It is also 
responsible for cell wall integrity and negative 
charge, and may be important in protection against 
antifungal agents and in binding of different ions 
(including iron) to the cell surface. Melanin helps 
C. neoformans escape the action of antifungal agents 
and to abrogate antibody-mediated phagocytosis 
(Buchanan & Murphy, 1998; Casadevall et al., 2000; 
Perfect, 2006). 
Mannitol production
Infection of the central nervous system caused 
by C. neoformans is often associated with production 
of a large amount of the hexitol d-mannitol by this 
organism (Liappis et al., 2008). This process may 
facilitate the development of meningoencephalitis, 
because mannitol increases the osmolality of the 
surrounding fluid, thus it may contribute to brain 
edema, and also prevents oxidative damage to the 
fungus (Wong et al., 1990). Polymorphonuclear neu-
trophils (PMN) can kill C. neoformans cells by gen-
erating toxic oxygen metabolites such as OH˙ and 
HOCl, which are thought to be key effector mol-
ecules against C. neoformans, but production of large 
amounts of mannitol can protect the fungi from 
oxidative killing by PMN or by cell-free oxidants 
(Chaturvedi et al., 1996a). Mannitol production is 
also thought to be helpful for the pathogen to resist 
other environmental stresses, since Chaturvedi et al. 
(1996b) showed that a C. neoformans mutant produc-
ing low levels of mannitol was more susceptible to 
heat stress and osmotic stress. The crucial enzyme 
for mannitol production by this pathogenic species 
is mannitol dehydrogenase (Perfect et al., 1996).
Adhesion to host cells and crossing the blood-brain 
barrier
When addressing the problem of C. neoformans 
adhesion to the host cells and proteins it is crucial to 
recognize all factors which have an influence on fun-
gal pathogenicity, but still the mechanism responsi-
ble for adhesion and adhesive structures present on 
the fungal cell wall, remain unknown. It was proven 
by Chang et al. (2004) that cryptococcal infection of 
the central nervous system must be preceded by ad-
hesion to the human brain microvascular endothelial 
cells (HBMEC), followed by transcellular crossing of 
the blood-brain barrier without disrupting the mon-
olayer integrity. Chang and coworkers showed that 
there no C. neoformans cells were present between 
HBMEC, so they excluded the possibility of cross-
ing the blood-brain barrier by C. neoformans via a 
paracellular mechanism. However, Olszewski et al. 
(2004) suggested that urease production by C. neo-
formans cells facilitates microcapillaries sequestration 
and disruption of endothelial cells and, in conse-
quence, crossing the blood-brain barrier via a para-
cellular mechanism. Other hypothetical mechanisms 
of central nervous system invasion by C. neoformans 
have been put forward. Santangelo et al. (2004) and 
Charlier et al. (2009) postulated that C. neoformans 
cells could invade the central nervous system by 
means of infected immune cells which could carry 
the pathogen within through the blood-brain bar-
rier (a “Trojan horse” mechanism). Those authors 
hypothesized that phagocytosed C. neoformans cells 
after delivery into the brain tissues can escape from 
phagocytes and continue invasion and tissue dam-
age due to the acidification of the environment and 
activation of extracellular phospholipases. C. neofro-
mans has other properties which help in the invasion 
of the central nervous system. According to Charlier 
et al. (2005), the size of C. neoformans cells and the 
modifications of the fungal capsule during central 
nervous system invasion suggest the existence of an 
active mechanism that may be triggered during or 
after crossing of the blood-brain barrier. C. neoform-
ans might induce considerable morphological chang-
es and actin reorganization after adhesion to the HB-
MEC surface, facilitating engulfment of the fungus 
by endothelial cells or alteration in tight junctions’ 
permeability (Chen et al., 2003). The mechanism of 
cryptococcal invasion of the central nervous system 
Figure 3. Cryptococcus neoformans melanogenesis pathway.
After Buchanan and Murphy (1998), modified.
218            2009J. Karkowska-Kuleta and others
is still unknown and requires further investigation, 
and so are the fungal properties that facilitate cross-
ing the blood-brain barrier. 
Other virulence factors
Probably at some stage of infection C. neo-
formans produces and secretes hydrolytic enzymes, 
such as proteases and phospholipases, which play 
a role in nutrition and tissue damage. Cryptococcal 
extracellular phospholipase exhibits phospholipase 
B (PLB), lysophospholipase (LPL) and lysophos-
pholipase-transacylase (LPTA) activities (Chen et al., 
2000). The action of this enzyme can result in desta-
bilization and destruction of the membranes and 
lung surfactant, cell lysis and release of lipid second 
messengers (Ghannoum, 2000; Cox et al., 2001). The 
phospholipase also enhances the adhesion of C. neo-
formans cells to the lung epithelium (Ganendren et al., 
2006). The activity of the phospholipase is strongly 
correlated with cryptococcal virulence, as proved by 
Cox et al. (2001) who constructed plb1 mutants which 
were significantly less virulent in animal models 
and had a growth defect in a macrophage-like cell 
line. Probably PLB plays an important role in intra-
cellular growth, survival and replication of C. neof-
romans within macrophages (Santangelo et al., 2004). 
One factor which might be involved in the survival 
of C. neoformans in the presence of macrophages is 
the production of eicosanoids: prostaglandins and 
leukotrienes, which can down-regulate macrophage 
functions (Noverr et al., 2003).  Moreover, the phos-
pholipase plays a role not only in the turnover of 
cryptococcal cell membrane but also in the mainte-
nance of cell wall integrity and therefore fungal sur-
vival, particularly during heat stress (Siafakas et al., 
2007). It is also known that C. neoformans possesses a 
proteolytic activity, but these findings must be still 
investigated (Buchanan & Murphy, 1998). Recently, 
a gene for aspartic proteinase was characterized 
and the three-dimensional structure of this protein 
was proposed (Pinti et al., 2007). This protein, called 
CnAP1, has two homologous domains, each contain-
ing an Asp residue in a conserved position (Pinti et 
al., 2007). The fungal resistance to reactive oxygen 
species is not only due to the mannitol and melanin 
production, but also very important is the produc-
tion of Cu, Zn superoxide dismutase, peroxidases, 
glutathione peroxidase and glutathione reductase, 
which play a role in resistance to oxidative and nit-
rosative species (Brown et al., 2007b). 
C. neoformans can also undergo phenotypic 
switching, when parent smooth colonies are changed 
into mucoid colonies which are more virulent dur-
ing lung infection and can modify the immunologi-
cal host response (Guerrero & Fries, 2008). Another 
very important virulence factor of C. neoformans is 
its ability to grow in the host’s physiological condi-
tions, i.e. at 37°C in an atmosphere of approx. 5% 
CO2 and a pH higher than 7.0 (Buchanan & Mur-
phy, 1998). For the fungal survival in the host organ-
ism the presence of an intact gene for calcineurin A 
is essential. Calcineurin A is a phosphoserine-phos-
phothreonine specific phosphatase encoded by the 
CNA1 gene (Odom et al., 1997). After activation by 
pathways connected with fungal stress response cal-
cineurin can dephosphorylate specific proteins re-
sponsible for pathogenicity and for growth within 
the host organism, but specific targets of this en-
zyme need still to be investigated. Disruption of the 
CNA1 gene can damage the fungal ability to grow 
at 37°C without affecting the ability to grow at 24°C 
(Odom et al., 1997). 
C. neoformans is also able to acquire iron from 
its environment during tissue and bloodstream in-
fections. The pathway of signaling of iron presence 
in the surroundings and iron acquisition is only par-
tially understood. Reductases present at the fungal 
cell surface can reduce ferric to ferrous iron. This 
process is followed by transport of the ferrous ions 
into the cell. This process is mediated by a permease 
(Cft1) and ferroxidase (Cfo1) complex connected 
with the plasma membrane (Jung & Kronstad, 2008). 
The siderophore transporter Sit1, the cell wall pro-
tein Cig1 and the mitochondrial proteins Frr1, 3 and 
4 also play roles in iron delivery and homeostasis. 
The Cir1 protein controls the transcription of genes 
encoding those proteins (Jung & Kronstad, 2008).
Aspergillus fumigAtus
Aspergillus fumigatus is an ascomycetous, 
saprophytic and ubiquitous fungus responsible for 
moulding. It is found worldwide and its small-sized 
conidia (2–3 μm) are abundant in the environment 
(Gniadek & Macura, 2007). Airborne A. fumigatus co-
nidia are inhaled by everyone, because their concen-
tration in the air is high, approx. 1–100 conidia per 
m3 (Latgé, 2001). It is also well known that A. fumig-
atus conidia are frequently present in food, especial-
ly in pepper and tea (Bouakline et al., 2000), in tap 
water (Warris et al., 2003), at home (Ren et al., 2001) 
and in the office rooms (Buczyńska et al., 2007). This 
may be the reason why nosocomial acquired infec-
tions and community acquired infections quite often 
develop in immunocompromised as well as in im-
munocompetent people (Clancy & Nguyen, 1998). In 
an immunocompetent person, the efficient immune 
system is usually able to get rid of these conidia, but 
sometimes even those people may contract invasive 
pulmonary aspergillosis (Clancy & Nguyen, 1998). 
However, especially patients with severely impaired 
immunity may contract a life-threatening invasive 
Vol. 56       219Virulence factors of pathogenic fungi
pulmonary disease, disseminated infections or cen-
tral nervous system infection (Latgé, 2001; Rhodes & 
Brakhage, 2006). A high mortality rate, from 60% to 
90%, is correlated with late diagnosis and relative-
ly poor knowledge about fungal pathogenicity and 
virulence factors (Tekaia & Latgé, 2005; Rementeria 
et al., 2005). There are some features thought to be 
putative virulence factors, including heat tolerance, 
adhesins, pigment production, toxic metabolites and 
extracellular enzymes, but most of them evolved 
as fungal protection against adverse environmental 
conditions and their role in pathogenicity is often 
unclear (Alp & Arikan, 2008). The functions and 
character of the putative virulence factors of A. fu-
migatus are still under investigation; probably there 
is a substantial co-operation between these prop-
erties, many of which are regulated by numerous 
genes, so it is often impossible to indicate without 
doubts which of them contribute to the mechanism 
of pathogenesis.
Melanin production
A. fumigatus conidia are often black or grey 
due to the presence in the cell wall of a pigment 
called DHN-melanin, which is synthesized from 
acetate with participation of enzymatic products of 
six genes (Fig. 4) (Tsai et al., 1999; Latgé, 2001). The 
melanin functions are protection against ultraviolet 
radiation, enzymatic lysis, extreme temperatures, as 
well as against reactive oxygen species during infec-
tion (Rementeria et al., 2005). 
Secreted hydrolytic enzymes
A. fumigatus produces and secretes various 
hydrolytic enzymes, including serine and aspartic 
protease, metalloproteinase, dipeptydylpeptidases 
and phospholipases, which contribute to fungal vir-
ulence facilitating lung and other tissue colonization. 
There is a considerable correlation between phos-
pholipase activity and severity of infection (Alp & 
Arikan, 2008). The serine proteinase and metallopro-
teinase have an elastinolytic activity, so lungs being 
rich in elastin, the A. fumigatus ability to degrade this 
protein is important during pulmonary infections 
(Hogan et al., 1996). The serine proteinase (AFA1p) 
is a member of subtilisin family and can degrade 
not only elastin but also collagen, fibrin and fibrino-
gen. This protein has an extracellular location, but it 
is also connected with the cell wall (Moutaouakil et 
al., 1993; Tomee & Kauffman, 2000). Apart from the 
mentioned activities, other hydrolytic enzymes are 
produced by A. fumigatus, including nucleases and 
phosphatases (Tomee & Kauffman, 2000).
Toxins
Secretion of different kinds of toxins to the 
environment or during infection within the human 
organism is one of the characteristic features of A. 
fumigatus. The well-known A. fumigatus toxin afla-
toxin, which has hepatotoxic and carcinogenic fea-
tures probably is not produced in the human or-
ganism during infection, because its expression is 
regulated by many genes under complex influence 
of environmental conditions (OBrian et al., 2003; 
Rementeria et al., 2005). The most important toxin 
with a well-proven in vivo activity is gliotoxin. This 
secondary metabolite from the epipolythiodioxopi-
perazine family has immunosuppressive properties, 
because it can inhibit macrophage phagocytosis, 
T-cell activation and proliferation, and can induce 
macrophage apoptosis (Hogan et al., 1996). Gliotoxin 
is also responsible for slowing ciliary beating in the 
respiratory tract and for epithelial layer damage, so 
the fungal cells cannot be efficiently removed from 
the host organism (Tomee & Kauffman, 2000). An-
other toxin secreted in vivo is resticotocin, an 18-
kDa protein (Aspf1) which cleaves a phosphodiester 
bond in 28S rRNA of eukaryotic ribosomes (Lamy et 
al., 1991; Hogan et al., 1996). A. fumigatus also pro-
Figure 4. Pathway for melanin synthesis by Aspergillus fumigatus.
After Latgé (2001), modified.
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duces other immunosuppressive toxins, for example 
the 14-kDa conidial inhibitory factor and AfD, A. fu-
migatus diffusible product. Pyrogenic, cytotoxic and 
shock-evoking activities are also characteristic for 
other endotoxins produced by A. fumigatus, includ-
ing fumitremorgins, fumagilin, fumagatin and hel-
volic acid (Tomee & Kauffman, 2000).
Other virulence factors
The molecular basis of A. fumigatus patho-
genicity is associated with its ability to adhere to 
host tissues and with binding to different host pro-
teins, including laminin, fibrinogen, surfactant A 
and D, complement, immunoglobulin and fibronec-
tin through different receptors connected with the 
fungal cell wall, which is built of α, β-1,3-glucan, 
galactomannan and chitin (Latgé, 2001). The ga-
lactomannan can be used as a diagnostic factor, 
because during infection it can be found in the se-
rum, urine and cerebrospinal fluid (Latgé, 1999; Re-
menteria et al., 2005). Probably laminin and fibrino-
gen have a common receptor or distinct receptors, 
but tightly packed on the surface of conidia (Tomee 
& Kauffman, 2000). A. fumigatus conidia are cov-
ered with a layer of hydrophobic proteins, called 
“rodlet layer” built from proteins encoded by at 
least two genes, RODA and RODB, responsible for 
adhesion to albumin and collagen (Latgé, 2001). 
Protection against reactive oxygen species pro-
duced by human immune cells during inflamma-
tory state is also important for developing a fungal 
infection, therefore A. fumigatus has an ability to 
produce catalases and superoxide dismutases (Lat-
gé, 2001). Three catalases are expressed by A. fumi-
gatus. CatA, a homodimeric enzyme composed of 
two 84.5-kDa subunits, is connected with conidia. 
The other two catalases, Cat1p and Cat2p, are con-
nected with hyphae and have different structures, 
because the first one is composed of four 90-kDa 
subunits, and the second is a monomer. Despite 
the fact that these enzymes can protect A. fumigatus 
against reactive oxygen species in the environment 
their role as virulence factors during infection is 
not clear (Paris et al., 2003). Perhaps there are other 
enzymes with such activity which contribute to the 
fungal pathogenicity. It has also been proven that 
A. fumigatus superoxide dismutases, containing Mn 
or Cu and Zn, can efficiently prevent the fungus 
from oxidative damage (Rementeria et al., 2005). 
The optimal temperature for A. fumigatus growth 
is 37°C, but it is able to grow even at 55°C and to 
survive temperatures near 75°C (Tekaia & Latgé, 
2005). There are some indications that calcineurin 
catalytic A subunit, encoded by the CNAA gene, is 
very important for A. fumigatus growth, tissue in-
vasion and pathogenicity (Steinbach et al., 2006).
COnCluSIOnS
The recent progress in medical techniques, 
transplantology and antimicrobial treatment is un-
fortunately the reason of the increasing frequency 
of invasive fungal infections and high mortality 
rate, even 90%, among patients with disseminated 
candidiasis, aspergillosis or cryptococcosis (Rich-
ardson, 2005). Additionally, the diagnosis is often 
difficult because of non-specific symptoms and 
problems in isolation and identification of fungi 
(Hinrikson et al., 2005). At present, the majority of 
pathogenic fungi are susceptible to conventional 
antifungal treatment, but an increasing resistance 
to some antifungal drugs is a new, important prob-
lem in medicine. Currently used antifungal drugs 
belong to one of four groups of different character 
and mechanism of action (Sanglard & White, 2006). 
The first group, the polyenes represented by am-
photericin B, target ergosterol, a sterol present in 
the fungal cell membrane, and make pores caus-
ing cell death (White et al., 1998). Amphotericin B 
may be used for treating infections caused by C. 
albicans, C. neoformans and A. fumigatus. The main 
problem with polyene therapy is that at high and 
efficient concentrations they are nephrotoxic and 
must be injected intravenously because of poor sol-
ubility (Sanglard & White, 2006).The second group 
of antifungal drugs is ergosterol biosynthesis in-
hibitors, which include azoles, morpholines and al-
lylamines. They can inhibit the late pathway of er-
gosterol biosynthesis and cell division, causing loss 
of membrane structure and function (White et al., 
1998). Azoles are the most popular drugs from this 
group, and they can be divided into two classes: 
imidazoles, which include ketoconazole and clot-
rimazole used for superficial infections, and tria-
zoles, which include fluconazole, voriconazole and 
itraconazole used for systemic infections (Sanglard 
& White, 2006). Azoles are used for treating can-
didiasis, but voriconazole is also important for as-
pergillosis therapy (Macura et al., 2000; Pawlik et 
al., 2006), whereas fluconazole is used for crypto-
coccosis therapy because of its ability to cross the 
blood-brain barrier (Sanglard & White, 2006). The 
third group includes inhibitors of nucleic acid syn-
thesis, i.e. 5-flucytosine (Sanglard & White, 2006). 
The fourth, the newest category of antifungal 
drugs, includes echinocandins which target glucan 
synthase. One echinocandin, caspofungin, is cur-
rently used for treatment of Candida and Aspergillus 
infections; other echinocandins, anidulafungin and 
micafungin, are in clinical trials (Sanglard & White, 
2006). A serious problem in treatment of fungal in-
fections is the resistance to azoles and 5-flucytosine 
through a mechanism dependent on alternations in 
the target enzyme and in drug efflux pumps (Es-
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pinel-Ingroff, 2008). A way to avoid developing 
resistance is to use multidrug therapy or different 
antifungal agents, as well as to limit too frequent 
and uncontrolled usage of the newest category of 
drugs (Sanglard & White, 2006). It is also necessary 
to recognize the mechanism of pathogen–host in-
teractions at the molecular level in order either to 
prevent the infection or to develop new strategies 
for therapy and new effective antifungal drugs. Al-
though the knowledge of the fungal pathogenicity 
and molecular basis of their virulence is already 
significant, this issue needs further investigation.
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